Sydney NET Patient Forum Brings Together Patients and Clinicians

NeuroEndocrine Cancer Australiau2019s Sydney NET Patient Forum was held at Royal North Shore Hospital on 28 October 2025, offering patients, families, and clinicians the chance to connect, learn, and share insights about the latest developments in neuroendocrine cancer care.

The evening began with light refreshments, followed by a welcome and opening remarks from the event chairs Prof Nick Pavlakis and Dr David Chan. Attendees then heard from an impressive line-up of expert speakers, including:

  • Claire Kent, Cancer Nurse Coordinator u2013 AUSNET Clinical Trial
  • Mr Kai Brown, HPB General Surgeon, RNSH u2013 Debulking Surgery in NETs and Management of Pancreatic NETs
  • Dr Richard Maher, Interventional Radiologist, RNSH (TBC) u2013 Radiology Update
  • Meredith Cummins, NECA CEO u2013 NECA Update

The evening concluded with a lively Q&A session, allowing patients to engage directly with the experts and share their experiences. Professor Rory Clifton-Bligh joined the Q&A panel and provided input on Endocrinology which a vital member of the Multidisciplinary Team in the management of NETs

NECA extends its heartfelt thanks to all presenters, attendees, and partners who made the event possible. Your participation continues to strengthen our shared commitment to improving diagnosis, treatment, and care for people living with neuroendocrine cancer. Our gratitude goes to Ipsen for sponsoring the recording of this event and catering.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Raising Awareness for NETs on World Cancer Day in WA

Australia delivers excellent cancer care, but not equally

AUS-NET Update, January 2026

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.